Investors gel with Shanghai Haohai IPO

Chinese small cap biomedical materials producer poised to benefit from liquidity-fuelled rally pushing Hong Kong stocks closer to A-share valuations.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES